Thomas Maloney

No ORCID on file · 2 papers in corpus

other 2021

Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's

Contemporary clinical trials ·doi:10.1016/j.cct.2021.106488

The LUCINDA Trial (Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's) is a 52 week, randomized, placebo-controlled trial of leuprolide acetate (Eligard) in women with Alzheimer's disease (AD). Leuprolide …

article 2021

Value and Interest Rates: Are Rates to Blame for Value’s Torments?

·doi:10.3905/jpm.2021.1.236

Objective Since conflicting results have been published on the role of tobacco smoking on the risk of endometriosis, we provide an up-to-date summary quantification of this potential association. Design We performed a PubMed/MEDLINE search …